Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

News from Washington: Patent challenge by MedImmune being considered by high court

Oct. 13, 2006

By Aaron Lorenzo

Genzyme, Now In Front For AnorMED, Reports Earnings

Oct. 13, 2006

By Aaron Lorenzo

Genzyme Corp., which has moved to the forefront of a bidding war for AnorMED Inc., on Thursday reported third-quarter earnings that came out ahead of consensus projections but nonetheless failed to impress many observers. (BioWorld Today)

Genzyme, Now In Front For AnorMED, Reports Earnings

Oct. 13, 2006

By Aaron Lorenzo

Genzyme Corp., which has moved to the forefront of a bidding war for AnorMED Inc., on Thursday reported third-quarter earnings that came out ahead of consensus projections but nonetheless failed to impress many observers. (BioWorld Today)

Antibacterial Firm Achaogen Gets $26M In Second Round

Oct. 12, 2006

By Aaron Lorenzo

Antibacterial Firm Achaogen Gets $26M In Second Round

Oct. 12, 2006

By Aaron Lorenzo

MedImmune Patent Challenge Goes Before Supreme Court

Oct. 11, 2006

By Aaron Lorenzo

MedImmune Patent Challenge Goes Before Supreme Court

Oct. 11, 2006

By Aaron Lorenzo

Memory Raises $32M To Shore Up R&D Endeavors

Oct. 10, 2006

By Aaron Lorenzo

Chimeric Researcher Relates Regenerative Organ Success

Oct. 10, 2006

By Anette Breindl and Aaron Lorenzo

Memory Raises $32M To Shore Up R&D Endeavors

Oct. 10, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...